Giraldo-Velásquez, M.F.; Pérez-Osorio, I.N.; Espinosa-Cerón, A.; Bárcena, B.M.; Calderón-Gallegos, A.; Fragoso, G.; Torres-Ramos, M.; Páez-MartÃnez, N.; Sciutto, E.
Intranasal Methylprednisolone Ameliorates Neuroinflammation Induced by Chronic Toluene Exposure. Pharmaceutics 2022, 14, 1195.
https://doi.org/10.3390/pharmaceutics14061195
AMA Style
Giraldo-Velásquez MF, Pérez-Osorio IN, Espinosa-Cerón A, Bárcena BM, Calderón-Gallegos A, Fragoso G, Torres-Ramos M, Páez-MartÃnez N, Sciutto E.
Intranasal Methylprednisolone Ameliorates Neuroinflammation Induced by Chronic Toluene Exposure. Pharmaceutics. 2022; 14(6):1195.
https://doi.org/10.3390/pharmaceutics14061195
Chicago/Turabian Style
Giraldo-Velásquez, Manuel F., Iván N. Pérez-Osorio, Alejandro Espinosa-Cerón, Brandon M. Bárcena, Arturo Calderón-Gallegos, Gladis Fragoso, Mónica Torres-Ramos, Nayeli Páez-MartÃnez, and Edda Sciutto.
2022. "Intranasal Methylprednisolone Ameliorates Neuroinflammation Induced by Chronic Toluene Exposure" Pharmaceutics 14, no. 6: 1195.
https://doi.org/10.3390/pharmaceutics14061195
APA Style
Giraldo-Velásquez, M. F., Pérez-Osorio, I. N., Espinosa-Cerón, A., Bárcena, B. M., Calderón-Gallegos, A., Fragoso, G., Torres-Ramos, M., Páez-MartÃnez, N., & Sciutto, E.
(2022). Intranasal Methylprednisolone Ameliorates Neuroinflammation Induced by Chronic Toluene Exposure. Pharmaceutics, 14(6), 1195.
https://doi.org/10.3390/pharmaceutics14061195